BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

463 related articles for article (PubMed ID: 19697379)

  • 1. Sensitivity of electrophysiological tests for upper and lower motor neuron dysfunction in ALS: a six-month longitudinal study.
    de Carvalho M; Swash M
    Muscle Nerve; 2010 Feb; 41(2):208-11. PubMed ID: 19697379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stratifying disease stages with different progression rates determined by electrophysiological tests in patients with amyotrophic lateral sclerosis.
    Liu XX; Zhang J; Zheng JY; Zhang S; Xu YS; Kang DX; Fan DS
    Muscle Nerve; 2009 Mar; 39(3):304-9. PubMed ID: 19208412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical features that distinguish PLS, upper motor neuron-dominant ALS, and typical ALS.
    Gordon PH; Cheng B; Katz IB; Mitsumoto H; Rowland LP
    Neurology; 2009 Jun; 72(22):1948-52. PubMed ID: 19487653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative objective markers for upper and lower motor neuron dysfunction in ALS.
    Mitsumoto H; Ulug AM; Pullman SL; Gooch CL; Chan S; Tang MX; Mao X; Hays AP; Floyd AG; Battista V; Montes J; Hayes S; Dashnaw S; Kaufmann P; Gordon PH; Hirsch J; Levin B; Rowland LP; Shungu DC
    Neurology; 2007 Apr; 68(17):1402-10. PubMed ID: 17452585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. F-Waves and the corticospinal lesion in amyotrophic lateral sclerosis.
    de Carvalho M; Scotto M; Lopes A; Swash M
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2002 Sep; 3(3):131-6. PubMed ID: 12495574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and neurophysiological evaluation of progression in amyotrophic lateral sclerosis.
    de Carvalho M; Scotto M; Lopes A; Swash M
    Muscle Nerve; 2003 Nov; 28(5):630-3. PubMed ID: 14571468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Objective markers for upper motor neuron involvement in amyotrophic lateral sclerosis].
    Iwata NK
    Brain Nerve; 2007 Oct; 59(10):1053-64. PubMed ID: 17969345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Motor unit number index (MUNIX) versus motor unit number estimation (MUNE): a direct comparison in a longitudinal study of ALS patients.
    Boekestein WA; Schelhaas HJ; van Putten MJ; Stegeman DF; Zwarts MJ; van Dijk JP
    Clin Neurophysiol; 2012 Aug; 123(8):1644-9. PubMed ID: 22321299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monitoring disease progression using high-density motor unit number estimation in amyotrophic lateral sclerosis.
    van Dijk JP; Schelhaas HJ; Van Schaik IN; Janssen HM; Stegeman DF; Zwarts MJ
    Muscle Nerve; 2010 Aug; 42(2):239-44. PubMed ID: 20544934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The natural history of primary lateral sclerosis.
    Gordon PH; Cheng B; Katz IB; Pinto M; Hays AP; Mitsumoto H; Rowland LP
    Neurology; 2006 Mar; 66(5):647-53. PubMed ID: 16534101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Motor unit number estimation (mune) as a quantitative measure of disease progression and motor unit reorganization in amyotrophic lateral sclerosis.
    Sartucci F; Maritato P; Moscato G; Orlandi G; Calabrese R; Domenici GL; Murri L
    Int J Neurosci; 2007 Sep; 117(9):1229-36. PubMed ID: 17654089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical neurophysiology in ALS.
    Inghilleri M; Iacovelli E
    Arch Ital Biol; 2011 Mar; 149(1):57-63. PubMed ID: 21412716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Motor unit number estimation, isometric strength, and electromyographic measures in amyotrophic lateral sclerosis.
    Bromberg MB; Forshew DA; Nau KL; Bromberg J; Simmons Z; Fries TJ
    Muscle Nerve; 1993 Nov; 16(11):1213-9. PubMed ID: 8413373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The natural history of central motor abnormalities in amyotrophic lateral sclerosis.
    Mills KR
    Brain; 2003 Nov; 126(Pt 11):2558-66. PubMed ID: 12937082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurophysiological measures in amyotrophic lateral sclerosis: markers of progression in clinical trials.
    de Carvalho M; Chio A; Dengler R; Hecht M; Weber M; Swash M
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2005 Mar; 6(1):17-28. PubMed ID: 16036422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. F wave study in amyotrophic lateral sclerosis: assessment of balance between upper and lower motor neuron involvement.
    Argyriou AA; Polychronopoulos P; Talelli P; Chroni E
    Clin Neurophysiol; 2006 Jun; 117(6):1260-5. PubMed ID: 16678483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The corticomotor threshold is not dependent on disease duration in amyotrophic lateral sclerosis (ALS).
    de Carvalho M; Evangelista T; Sales-Luís ML
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2002 Mar; 3(1):39-42. PubMed ID: 12061947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in motor unit numbers in patients with ALS: a longitudinal study using the adapted multiple point stimulation method.
    Wang FC; Bouquiaux O; De Pasqua V; Delwaide PJ
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2002 Mar; 3(1):31-8. PubMed ID: 12061946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can selection of rapidly progressing patients shorten clinical trials in amyotrophic lateral sclerosis?
    de Carvalho M; Swash M
    Arch Neurol; 2006 Apr; 63(4):557-60. PubMed ID: 16606769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitating progression in ALS.
    de Carvalho M; Scotto M; Lopes A; Swash M
    Neurology; 2005 May; 64(10):1783-5. PubMed ID: 15911812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.